The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 19, 2023
Filed:
Jul. 14, 2020
Applicant:
Aerin Medical Inc., Sunnyvale, CA (US);
Inventors:
Scott J. Wolf, Menlo Park, CA (US);
Andrew Frazier, Sunnyvale, CA (US);
Assignee:
Aerin Medical Inc., Sunnyvale, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/12 (2006.01); A61B 17/24 (2006.01); A61B 18/08 (2006.01); A61B 18/06 (2006.01); A61B 18/14 (2006.01); A61N 5/06 (2006.01); A61N 5/02 (2006.01); A61F 5/56 (2006.01); A61B 18/16 (2006.01); A61B 17/28 (2006.01); A61N 1/40 (2006.01); A61F 7/10 (2006.01); A61B 5/01 (2006.01); A61F 5/08 (2006.01); A61B 18/02 (2006.01); A61B 18/00 (2006.01); A61B 18/18 (2006.01); A61B 18/20 (2006.01); A61B 17/32 (2006.01); A61N 7/02 (2006.01); A61B 18/04 (2006.01); A61M 25/10 (2013.01);
U.S. Cl.
CPC ...
A61B 17/24 (2013.01); A61B 5/01 (2013.01); A61B 17/2816 (2013.01); A61B 18/06 (2013.01); A61B 18/085 (2013.01); A61B 18/12 (2013.01); A61B 18/1206 (2013.01); A61B 18/14 (2013.01); A61B 18/1442 (2013.01); A61B 18/1445 (2013.01); A61B 18/1477 (2013.01); A61B 18/1485 (2013.01); A61B 18/16 (2013.01); A61F 5/08 (2013.01); A61F 5/56 (2013.01); A61F 7/10 (2013.01); A61N 1/403 (2013.01); A61N 5/025 (2013.01); A61N 5/0603 (2013.01); A61N 5/0625 (2013.01); A61B 17/320068 (2013.01); A61B 18/02 (2013.01); A61B 18/1815 (2013.01); A61B 18/20 (2013.01); A61B 2017/248 (2013.01); A61B 2018/00005 (2013.01); A61B 2018/0016 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00023 (2013.01); A61B 2018/0091 (2013.01); A61B 2018/00178 (2013.01); A61B 2018/00327 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00595 (2013.01); A61B 2018/00642 (2013.01); A61B 2018/00702 (2013.01); A61B 2018/00708 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/00821 (2013.01); A61B 2018/00875 (2013.01); A61B 2018/00886 (2013.01); A61B 2018/00922 (2013.01); A61B 2018/00928 (2013.01); A61B 2018/00982 (2013.01); A61B 2018/00994 (2013.01); A61B 2018/0212 (2013.01); A61B 2018/0225 (2013.01); A61B 2018/0262 (2013.01); A61B 2018/044 (2013.01); A61B 2018/126 (2013.01); A61B 2018/1253 (2013.01); A61B 2018/143 (2013.01); A61B 2018/1425 (2013.01); A61B 2018/1467 (2013.01); A61B 2018/1807 (2013.01); A61B 2018/1861 (2013.01); A61M 2025/105 (2013.01); A61N 7/022 (2013.01); F04C 2270/041 (2013.01);
Abstract
A method for reshaping a nasal airway in a patient involves advancing an inflatable balloon of a reshaping device in an uninflated configuration into a nostril of the patient and between a nasal septum and a lateral wall of the nasal airway. The method then involves inflating the inflatable balloon to an inflated configuration to cause the inflatable balloon to contact nasal mucosa covering the nasal septum and the lateral wall, delivering energy from an energy delivery member attached to or inside of the inflatable balloon, and removing the reshaping device from the nasal airway.